$117.3 million
in quarterly revenue, led by $90.6
million of Thermal Barrier revenue
Continued cost
discipline delivered 42% company gross margins and 22% Adjusted
EBITDA margins
Increased 2024 Financial Outlook to
$450 million of revenue, $9 million of net income, and $90 million of Adjusted EBITDA
Various
financing activities completed to fully-fund growth
strategy
NORTHBOROUGH, Mass., Nov. 6, 2024
/PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN)
("Aspen" or the "Company"), a
technology leader in sustainability and electrification solutions,
today announced financial results for the third quarter of 2024,
and discussed recent business developments.
Total revenue for the third quarter of 2024 was $117.3 million, compared to $60.8 million in the third quarter of
2023. Net loss was $13.0
million, which included a $27.5
million one-time charge from the redemption of the Company's
convertible note, compared to a net loss of $13.1 million in the third quarter of 2023. Net
loss per share was $0.17, compared to
a net loss per share of $0.19 in the
third quarter of 2023.
Adjusted EBITDA for the third quarter of 2024 was $25.4 million, compared to $(7.3) million in the third quarter of 2023. A
reconciliation of net income (loss) to Adjusted EBITDA is provided
in the financial schedules that are part of this press release. An
explanation of this non-GAAP financial measure is also included
below under the heading "Non-GAAP Financial Measures."
Recent Business Highlights & Quarterly
Performance
- Company revenue of $117.3
million, up 93% year-over-year (YoY)
- Thermal Barrier: $90.6 million of revenue,
up 176% YoY
- Energy Industrial: $26.8 million of supply
constrained revenue, down 4% YoY
- Completed 5-week turnaround of external manufacturing facility
to enable expanded supply capacity for Energy Industrial
segment
- Delivered gross margins of 42%, a 19-percentage point
improvement YoY
- Net loss of $13.0 million, which
included a $27.5 million one-time
charge from the redemption of the Company's convertible note, a
$0.1 million improvement YoY.
Adjusting net income for the above one-time charge would result in
net income of $14.5 million, a
$27.4 million YoY improvement
- Adjusted EBITDA of $25.4 million
(22% margin), a $32.6 million
improvement YoY
- Operating income of $17.4
million, a $32.0 million
improvement YoY
- Cash generated from operations of $20.8
million in the quarter
- Ended third quarter of 2024 with cash and equivalents of
$113.5 million
Recent Financing Activity
- On August 19, 2024, closed on
$125 million term loan facility and
drew $43 million of $100 million capacity asset-based revolving
credit facility with MidCap Financial, a leading commercial
finance company managed by Apollo Capital Management, L.P.
- The proceeds from the above transaction were utilized for the
full cash redemption of the Company's legacy convertible note of
$150.0 million
- On October 16, 2024, the Company
announced that it had received conditional commitment from the U.S.
Department of Energy Loan Programs Office for a proposed loan of up
to $670.6 million for financing the
construction of its planned second aerogel manufacturing
facility ("Statesboro Plant") in Statesboro, Georgia – full press release
link
- On October 21, 2024, closed
underwritten public offering with net proceeds of approximately
$93.2 million for funding
growth CAPEX and to enable opportunistic near-term
investment
"We are fully capitalized to execute our current strategy and
are well-positioned for continued profitable growth," noted
Don Young, Aspen's President and CEO. "During Q3, we
implemented process improvements at our external manufacturing
facility aimed at expanding capacity to meet the growing demand of
our Energy Industrial business. Our Thermal Barrier business
continues to show strength as our OEM customers ramp production,
and our long-term conviction in this segment remains unchanged. We
believe we are on track to utilize our existing assets and supply
arrangements to achieve our target of at least $650 million in annual revenue with at least 35%
gross margins and 25% Adjusted EBITDA margins. Our performance this
quarter once again demonstrated our ability to deliver these
profitability targets. As we plan additional capacity with our
Statesboro Plant, we remain focused on enhancing this margin
profile for the long-term."
Updated 2024 Financial Outlook
Aspen updated its 2024 full year outlook as
follows:
($ in millions,
except per share amounts)
|
|
|
|
Metric
|
February
(2/12/2024)
|
May
Update
(5/1/2024)
|
August
Update
(8/7/2024)
|
Current
Outlook
|
Δ Over August
Update
|
Revenue
|
>350
|
>380
|
>390
|
450
|
60
|
YoY Growth
|
47 %
|
59 %
|
63 %
|
88 %
|
Net Income
(Loss)*
|
>(23)
|
>2
|
>7
|
9*
|
2
|
Adjusted
EBITDA
|
>30
|
>55
|
>60
|
90
|
30
|
Earnings Per
Share
(Diluted)
|
>(0.30)
|
>0.03
|
>0.09
|
0.11*
|
0.02
|
*Current 2024 Outlook now includes a $27.5 million one-time charge from the
extinguishment of the Company's convertible note on August 19, 2024 and updated share count from
October 21, 2024 primary share
offering.
The Company's 2024 outlook assumes depreciation and amortization
of $25 million, stock-based
compensation expense of $14 million,
loss on extinguishment of debt of $27.5
million, other (income) expense and income tax expense of
$14.5 million, and diluted weighted
average shares outstanding of 84.0 million for the full year.
Ricardo C. Rodriguez, Chief
Financial Officer and Treasurer, added, "Q3 was productive with a
range of successful financing transactions aimed at lowering our
cost of capital and fully funding our current strategy as we
continue to execute. From our original outlook, we have increased
our revenue by $100M and Adjusted
EBITDA by $60M, 3X our original
expectations. Looking ahead to 2025, we expect continued growth
while driving the margin profile that our team has worked so hard
to achieve in 2024."
A reconciliation of net income to Adjusted EBITDA for the 2024
financial outlook is provided in the financial schedules that are
part of this press release. An explanation of this non-GAAP
financial measure is also included below under the heading
"Non-GAAP Financial Measures."
Aspen may incur, among other
items, additional charges, realize gains or losses, incur financing
costs or interest expense, or experience other events in 2024,
including those related to the planned capacity expansion, supply
chain disruptions, or further cost inflation, that could cause
actual results to vary materially from this outlook. See "Special
Note Regarding Forward-Looking and Cautionary Statements"
below.
Last Twelve-Month Financial Comparison
A comparison of
key financial metrics for the trailing twelve-month periods ended
September 30, 2023 and 2024:
($ in millions,
numbers may not total due to rounding)
|
Metric
|
|
LTM Q3
2023
|
LTM Q3
2024
|
Delta
|
%
Improvement
|
|
Revenue
|
|
214
|
414
|
200
|
93 %
|
|
Gross
Profit
|
|
42
|
165
|
124
|
297 %
|
|
|
%
Margin
|
19 %
|
40 %
|
|
Net Income
(Loss)
|
|
(55)
|
1
|
56
|
103 %
|
|
|
%
Margin
|
(26 %)
|
0 %
|
|
Adjusted
EBITDA
|
|
(37)
|
76
|
113
|
309 %
|
|
|
%
Margin
|
(17 %)
|
18 %
|
|
Operating
Income
|
|
(60)
|
41
|
101
|
168 %
|
|
|
%
Margin
|
(28 %)
|
10 %
|
|
Total
CAPEX
|
|
206
|
99
|
(107)
|
52 %
|
|
Conference Call and Webcast Notification
A conference
call with Aspen management to
discuss third quarter 2024 results and recent business developments
will be held on Thursday, November 7,
2024, at 8:30 a.m. ET. During
the call, management will respond to questions concerning, but not
limited to, Aspen's financial
performance, business conditions, and financial outlook.
Management's discussion and responses could contain information
that has not been previously disclosed.
Shareholders and other interested parties may call +1 (833)
470-1428 (domestic) or +1 (929) 526-1599 (international) and
reference conference ID "921873" to participate in the conference
call. In addition, the conference call and an accompanying slide
presentation will be available live as a listen-only webcast hosted
at the Investors section of Aspen's website, www.aerogel.com.
Following the live event, an archived version of the webcast
will be available on Aspen's
website for convenient on-demand replay for at least a year. A copy
of this press release is posted in the Investors section on
Aspen's website.
Non-GAAP Financial Measures
In addition to providing
financial measurements based on generally accepted accounting
principles in the United States of
America ("GAAP"), Aspen
provides an additional financial metric that is not prepared in
accordance with GAAP ("non-GAAP"). The non-GAAP financial measure
included in this press release is Adjusted EBITDA. Management uses
this non-GAAP financial measure, in addition to GAAP financial
measures, as a measure of operating performance because the
non-GAAP financial measure does not include the impact of items
that management does not consider indicative of Aspen's core operating performance. In
addition, management uses Adjusted EBITDA (i) for planning
purposes, including the preparation of Aspen's annual operating budget, (ii) to
allocate resources to enhance the financial performance of its
business, and (iii) as a performance measure under its bonus
plan.
Management believes that this non-GAAP financial measure
reflects Aspen's ongoing business
in a manner that allows for meaningful comparisons and analysis of
trends in its business, as it excludes expenses and gains not
reflective of Aspen's ongoing
operating results or that may be infrequent and/or unusual in
nature. Management also believes that this non-GAAP financial
measures provides useful information to investors in understanding
and evaluating Aspen's operating
results and future prospects in the same manner as management and
in comparing financial results across accounting periods and to
those of peer companies. This non-GAAP measure may not be
comparable to similarly titled measures presented by other
companies.
The non-GAAP financial measure does not replace the presentation
of Aspen's GAAP financial results
and should only be used as a supplement to, not as a substitute
for, Aspen's financial results
presented in accordance with GAAP. In this press release,
Aspen has provided a
reconciliation of Adjusted EBITDA to net income (loss), the most
directly comparable GAAP financial measure. Management strongly
encourages investors to review Aspen's financial statements and publicly
filed reports in their entirety and not rely on any single
financial measure.
About Aspen Aerogels, Inc.
Aspen is a technology leader in sustainability
and electrification solutions. The Company's aerogel technology
enables its customers and partners to achieve their own objectives
around the global megatrends of resource efficiency, e-mobility,
and clean energy. Aspen's
PyroThin® products enable solutions to thermal runaway challenges
within the electric vehicle ("EV") market. Aspen Battery Materials,
the Company's carbon aerogel initiative, seeks to increase the
performance of lithium-ion battery cells to enable EV manufacturers
to extend the driving range and reduce the cost of EVs. The
Company's Cryogel® and Pyrogel® products are valued by the world's
largest energy infrastructure companies. Aspen's strategy is to partner with
world-class industry leaders to leverage its Aerogel Technology
Platform® into additional high-value markets. Aspen is headquartered in Northborough, Mass. For more information,
please visit www.aerogel.com.
Special Note Regarding Forward-Looking and Cautionary
Statements
This press release and any related discussion
contains "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995 that involve risks
and uncertainties that could cause actual results to be materially
different from historical results or from any future results
expressed or implied by such forward-looking statements, including
statements relating to Aspen's
2024 financial outlook. These statements are not historical facts
but rather are based on Aspen's
current expectations, estimates and projections regarding
Aspen's business, operations and
other factors relating thereto, including with respect to
Aspen's 2024 financial outlook.
Words such as "may," "will," "could," "would," "should,"
"anticipate," "predict," "potential," "continue," "expects,"
"intends," "plans," "projects," "believes," "estimates," "outlook,"
"assumes," "targets," "opportunity," and similar expressions are
used to identify these forward-looking statements. Such
forward-looking statements include statements regarding, among
other things, Aspen's beliefs and
expectations about capacity, revenue, revenue capacity, backlog,
costs, expenses, profitability, cash flow, gross profit, gross
margin, operating margin, net income (loss), Adjusted EBITDA and
related increases, decreases, trends or timing, including with
respect to Aspen's beliefs and
expectations about the EV market and how it may enable a path to
profitability; Aspen's target
revenue capacity and gross margins; Aspen's efforts to manage the construction of
the planned second manufacturing plant in Statesboro Georgia to align with our
expectations of demand from EV customers, and the use of our
external manufacturing facility to meet demand from Energy
Industrial customers; current or future trends in the energy,
energy infrastructure, chemical and refinery, LNG, sustainable
building materials, EV thermal barrier, EV battery materials or
other markets and the impact of these trends on Aspen's business; the strength, effectiveness,
productivity, costs, profitability or other fundamentals of
Aspen's business; beliefs about
the role of Aspen's technology and
opportunities in the electric vehicle market; beliefs about
Aspen's ability to provide and
deliver products and services to electric vehicle customers;
beliefs about content per vehicle, revenue, costs, expenses,
profitability, investments or cash flow associated with
Aspen's electric vehicle
opportunities, including the EV thermal barrier business; the
performance and market acceptance of Aspens' products; and
Aspen's conditional commitment
from the DOE for a proposed loan pursuant to the DOE LPO's ATVM and
Aspen's expectations and beliefs
with respect to the potential receipt of the loan. All such
forward-looking statements are based on management's present
expectations and are subject to certain factors, risks and
uncertainties that may cause actual results, outcome of events,
timing and performance to differ materially from those expressed or
implied by such statements. These risks and uncertainties include,
but are not limited to, the following: inability to execute
Aspen's growth plan, inability to
continue construction of the planned second manufacturing plant and
to do so at a cost consistent with Aspen's estimates and aligned with
Aspen's expectations of demand
from our EV customers; the right of EV thermal barrier customers to
cancel contracts with Aspen at any
time and without penalty; any costs, expenses, or investments
incurred by Aspen in excess of
projections used to develop pricing under the contracts with EV
thermal barrier customers; Aspen's
inability to create customer or market opportunities for its
products; any disruption or inability to achieve expected capacity
levels in any of its manufacturing or assembly facilities; any
failure to enforce any of Aspen's
patents; the general economic conditions and cyclical demands in
the markets that Aspen serves; and
the other risk factors discussed under the heading "Risk Factors"
in Aspen's Annual Report on Form
10-K for the year ended December 31,
2023 and filed with the Securities and Exchange Commission
("SEC") on March 7, 2024, as well as
any updates to those risk factors filed from time to time in
Aspen's subsequent periodic and
current reports filed with the SEC. All statements contained in
this press release are made only as of the date of this press
release. Aspen does not intend to
update this information unless required by law.
ASPEN AEROGELS,
INC.
Condensed
Consolidated Balance Sheets
(Unaudited and in
thousands)
|
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2024
|
|
|
2023
|
|
|
|
(In
thousands)
|
|
Assets
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
113,489
|
|
|
$
|
139,723
|
|
Restricted
cash
|
|
|
394
|
|
|
|
248
|
|
Accounts receivable,
net
|
|
|
115,199
|
|
|
|
69,995
|
|
Inventories
|
|
|
47,430
|
|
|
|
39,189
|
|
Prepaid expenses and
other current assets
|
|
|
29,344
|
|
|
|
17,176
|
|
Total current
assets
|
|
|
305,856
|
|
|
|
266,331
|
|
Property, plant and
equipment, net
|
|
|
451,569
|
|
|
|
417,227
|
|
Operating lease
right-of-use assets
|
|
|
20,373
|
|
|
|
17,212
|
|
Other long-term
assets
|
|
|
4,789
|
|
|
|
2,278
|
|
Total
assets
|
|
$
|
782,587
|
|
|
$
|
703,048
|
|
Liabilities and
Stockholders' Equity
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
42,280
|
|
|
$
|
51,094
|
|
Accrued
expenses
|
|
|
26,531
|
|
|
|
22,811
|
|
Deferred
revenue
|
|
|
2,405
|
|
|
|
2,316
|
|
Finance obligation for
sale and leaseback transactions
|
|
|
3,653
|
|
|
|
—
|
|
Operating lease
liabilities
|
|
|
3,181
|
|
|
|
1,874
|
|
Long term debt -
current portion
|
|
|
26,250
|
|
|
|
—
|
|
Total current
liabilities
|
|
|
104,300
|
|
|
|
78,095
|
|
Revolving line of
credit
|
|
|
42,735
|
|
|
|
—
|
|
Long term
debt
|
|
|
93,674
|
|
|
|
—
|
|
Convertible note -
related party
|
|
|
—
|
|
|
|
114,992
|
|
Finance obligation for
sale and leaseback transactions long-term
|
|
|
10,486
|
|
|
|
—
|
|
Operating lease
liabilities long-term
|
|
|
23,742
|
|
|
|
21,906
|
|
Total
liabilities
|
|
|
274,937
|
|
|
|
214,993
|
|
Stockholders'
equity:
|
|
|
|
|
|
|
Total stockholders'
equity
|
|
|
507,650
|
|
|
|
488,055
|
|
Total liabilities and
stockholders' equity
|
|
$
|
782,587
|
|
|
$
|
703,048
|
|
ASPEN AEROGELS,
INC.
Consolidated
Statements of Operations
(Unaudited and in
thousands, except share and per share data)
|
|
|
|
Three Months
Ended
|
|
|
Nine Months
Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
|
|
(In thousands,
except
share and per share data)
|
|
Revenue
|
|
$
|
117,340
|
|
|
$
|
60,755
|
|
|
$
|
329,611
|
|
|
$
|
154,499
|
|
Cost of
revenue
|
|
|
68,297
|
|
|
|
46,945
|
|
|
|
193,847
|
|
|
|
127,196
|
|
Gross
profit
|
|
|
49,043
|
|
|
|
13,810
|
|
|
|
135,764
|
|
|
|
27,303
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and
development
|
|
|
4,591
|
|
|
|
4,218
|
|
|
|
13,645
|
|
|
|
12,281
|
|
Sales and
marketing
|
|
|
9,306
|
|
|
|
8,386
|
|
|
|
27,130
|
|
|
|
24,226
|
|
General and
administrative
|
|
|
17,746
|
|
|
|
15,840
|
|
|
|
52,465
|
|
|
|
41,382
|
|
Impairment of
equipment under development
|
|
|
—
|
|
|
|
—
|
|
|
|
2,702
|
|
|
|
—
|
|
Total operating
expenses
|
|
|
31,643
|
|
|
|
28,444
|
|
|
|
95,942
|
|
|
|
77,889
|
|
Income (loss) from
operations
|
|
|
17,400
|
|
|
|
(14,634)
|
|
|
|
39,822
|
|
|
|
(50,586)
|
|
Other income
(expense)
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense,
convertible note - related party
|
|
|
(1,469)
|
|
|
|
(1,938)
|
|
|
|
(7,550)
|
|
|
|
(2,424)
|
|
Interest income
(expense)
|
|
|
(1,147)
|
|
|
|
1,313
|
|
|
|
(883)
|
|
|
|
5,532
|
|
Income from Employee
Retention Credits
|
|
|
—
|
|
|
|
2,186
|
|
|
|
—
|
|
|
|
2,186
|
|
Loss on extinguishment
of debt
|
|
|
(27,487)
|
|
|
|
—
|
|
|
|
(27,487)
|
|
|
|
—
|
|
Total other income
(expense)
|
|
|
(30,103)
|
|
|
|
1,561
|
|
|
|
(35,920)
|
|
|
|
5,294
|
|
Income (loss) before
income tax expense
|
|
|
(12,703)
|
|
|
|
(13,073)
|
|
|
|
3,902
|
|
|
|
(45,292)
|
|
Income tax
expense
|
|
|
(267)
|
|
|
|
—
|
|
|
|
(1,889)
|
|
|
|
—
|
|
Net income
(loss)
|
|
$
|
(12,970)
|
|
|
$
|
(13,073)
|
|
|
$
|
2,013
|
|
|
$
|
(45,292)
|
|
Net income (loss) per
share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.17)
|
|
|
$
|
(0.19)
|
|
|
$
|
0.03
|
|
|
$
|
(0.65)
|
|
Diluted
|
|
$
|
(0.17)
|
|
|
$
|
(0.19)
|
|
|
$
|
0.03
|
|
|
$
|
(0.65)
|
|
Weighted-average common
shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
76,261,294
|
|
|
|
69,317,805
|
|
|
|
76,402,123
|
|
|
|
69,243,843
|
|
Diluted
|
|
|
76,261,294
|
|
|
|
69,317,805
|
|
|
|
79,149,193
|
|
|
|
69,243,843
|
|
Analysis of Cash Flow
The following table summarizes
our cash flows for the periods indicated.
|
|
Three Months
Ended
|
|
|
|
March 31,
2024
|
|
|
June 30,
2024
|
|
|
September 30,
2024
|
|
|
|
|
|
|
(In
thousands)
|
|
|
|
|
|
Net cash provided by
(used in):
|
|
|
|
|
|
|
|
|
|
Operating
activities
|
|
$
|
(17,749)
|
|
|
$
|
6,843
|
|
|
$
|
20,771
|
|
Investing
activities
|
|
|
(25,863)
|
|
|
|
(24,827)
|
|
|
|
(20,821)
|
|
Financing
activities
|
|
|
5,259
|
|
|
|
8,141
|
|
|
|
22,158
|
|
Net (decrease) increase
in cash
|
|
|
(38,353)
|
|
|
|
(9,843)
|
|
|
|
22,108
|
|
Cash, cash equivalents
and restricted cash at beginning of period
|
|
|
139,971
|
|
|
|
101,618
|
|
|
|
91,775
|
|
Cash, cash equivalents
and restricted cash at end of period
|
|
$
|
101,618
|
|
|
$
|
91,775
|
|
|
$
|
113,883
|
|
Reconciliation of Non-GAAP Financial Measures
The
following tables present a reconciliation of the non-GAAP financial
measure included in this press release to the most directly
comparable GAAP measure:
Reconciliation of Adjusted EBITDA to Net loss
We
define Adjusted EBITDA as net income (loss) before interest
expense, taxes, depreciation, amortization, stock-based
compensation expense and other items, which occur from time to time
and which we do not believe are indicative of our core operating
performance.
For the three and nine months ended September 30, 2024 and 2023:
|
|
Three Months
Ended
|
|
|
Nine Months
Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
|
|
(In
thousands)
|
|
Net income
(loss)
|
|
$
|
(12,970)
|
|
|
$
|
(13,073)
|
|
|
$
|
2,013
|
|
|
$
|
(45,292)
|
|
Depreciation and
amortization
|
|
|
5,321
|
|
|
|
4,550
|
|
|
|
17,093
|
|
|
|
10,757
|
|
Stock-based
compensation
|
|
|
2,630
|
|
|
|
2,789
|
|
|
|
10,307
|
|
|
|
7,766
|
|
Other expense
(income)
|
|
|
2,616
|
|
|
|
(1,561)
|
|
|
|
8,433
|
|
|
|
(5,294)
|
|
Loss on extinguishment
of debt
|
|
|
27,487
|
|
|
|
-
|
|
|
|
27,487
|
|
|
|
-
|
|
Income tax
expense
|
|
|
267
|
|
|
|
-
|
|
|
|
1,889
|
|
|
|
-
|
|
Adjusted
EBITDA
|
|
$
|
25,351
|
|
|
$
|
(7,295)
|
|
|
$
|
67,222
|
|
|
$
|
(32,063)
|
|
For the trailing twelve months ended September 30, 2024 and 2023:
|
|
Last Twelve
Months
|
|
|
|
September 30,
|
|
|
|
2024
|
|
|
2023
|
|
|
|
(In
thousands)
|
|
Net income
(loss)
|
|
$
|
1,494
|
|
|
$
|
(54,901)
|
|
Depreciation and
amortization
|
|
|
21,654
|
|
|
|
13,287
|
|
Stock-based
compensation
|
|
|
13,495
|
|
|
|
10,438
|
|
Other expense
(income)
|
|
|
10,335
|
|
|
|
(5,351)
|
|
Loss on extinguishment
of debt
|
|
|
27,487
|
|
|
|
-
|
|
Income tax
expense
|
|
|
1,889
|
|
|
|
-
|
|
Adjusted
EBITDA
|
|
$
|
76,354
|
|
|
$
|
(36,527)
|
|
For the 2024 full year financial outlook:
|
|
Year
Ending
|
|
|
|
December 31,
2024
|
|
|
|
Current
|
|
|
August
Update
|
|
|
May
Update
|
|
|
February
|
|
|
|
(In
thousands)
|
|
Net income
(loss)
|
|
$
|
9,000
|
|
|
$
|
7,000
|
|
|
$
|
2,000
|
|
|
$
|
(23,000)
|
|
Depreciation and
amortization
|
|
|
25,000
|
|
|
|
30,000
|
|
|
|
30,000
|
|
|
|
30,000
|
|
Stock-based
compensation
|
|
|
14,000
|
|
|
|
14,000
|
|
|
|
14,000
|
|
|
|
14,000
|
|
Other expense, net and
income tax expense
|
|
|
14,500
|
|
|
|
9,000
|
|
|
|
9,000
|
|
|
|
9,000
|
|
Loss on extinguishment
of debt
|
|
|
27,500
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Adjusted
EBITDA
|
|
$
|
90,000
|
|
|
$
|
60,000
|
|
|
$
|
55,000
|
|
|
$
|
30,000
|
|
View original
content:https://www.prnewswire.com/news-releases/aspen-aerogels-inc-reports-third-quarter-2024-financial-results-and-recent-business-highlights-302298009.html
SOURCE Aspen Aerogels, Inc.